The Turkish Competition Authority publishes a decision on export bans in the pharmaceutical sector (Roche)

Introduction On 27 September 2018, Turkish Competition Authority (“TCA”) published its decision [1] concerning the allegations that Roche Müstahzarları A.Ş. (“Roche”) had violated articles 4 and 6 of the Law on the Protection of Competition (“Competition Act”). Within this scope, the TCA re-evaluated whether (i) Roche’s agreement with a pharmaceutical wholesaler, Co-Re-Na Ecza Deposu Dış. Tic. Ltd. Şti. (“CORENA”), which imposed an export ban on the buyer and (ii) its alleged interference with other wholesalers for interrupting their supply of goods to CORENA is in accordance with the law. This decision is crucial as it will shed some light on the TCA’s approach towards export ban clauses. As will be explained below, the TCA insisted on its previous conclusion that the export ban in the agreement

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Bahadır Balkı, The Turkish Competition Authority publishes a decision on export bans in the pharmaceutical sector (Roche), 27 September 2018, e-Competitions Bulletin November 2018, Art. N° 88210

Visites 353

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues